COMBINING IMMUNE CHECKPOINT INHIBITOR WITH LENVATINIB PROLONGS SURVIVAL THAN LENVATINIB ALONE IN SORAFENIB-EXPERIENCED HEPATOCELLULAR CARCINOMA PATIENTS

Po-Ting Lin; Wei Teng; Wen-Juei Jeng; Chun-Yen Lin; Hsi-Ming Lin; I-Shyan Sheen

COMBINING IMMUNE CHECKPOINT INHIBITOR WITH LENVATINIB PROLONGS SURVIVAL THAN LENVATINIB ALONE IN SORAFENIB-EXPERIENCED HEPATOCELLULAR CARCINOMA PATIENTS

Po-Ting Lin, Wei Teng, Wen-Juei Jeng, Chun-Yen Lin, Hsi-Ming Lin, I-Shyan Sheen

School of Medicine

Research output: Contribution to journal › Journal Article › peer-review

Original language	American English
Journal	Hepatology
Volume	72
State	Published - 2020

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

@article{249f4b07a1d548c4b2d3bf4132e52530,

title = "COMBINING IMMUNE CHECKPOINT INHIBITOR WITH LENVATINIB PROLONGS SURVIVAL THAN LENVATINIB ALONE IN SORAFENIB-EXPERIENCED HEPATOCELLULAR CARCINOMA PATIENTS",

author = "Po-Ting Lin and Wei Teng and Wen-Juei Jeng and Chun-Yen Lin and Hsi-Ming Lin and I-Shyan Sheen",

year = "2020",

language = "American English",

volume = "72",

journal = "Hepatology",

issn = "0270-9139",

publisher = "Lippincott Williams and Wilkins",

}

TY - JOUR

T1 - COMBINING IMMUNE CHECKPOINT INHIBITOR WITH LENVATINIB PROLONGS SURVIVAL THAN LENVATINIB ALONE IN SORAFENIB-EXPERIENCED HEPATOCELLULAR CARCINOMA PATIENTS

AU - Lin, Po-Ting

AU - Teng, Wei

AU - Jeng, Wen-Juei

AU - Lin, Chun-Yen

AU - Lin, Hsi-Ming

AU - Sheen, I-Shyan

PY - 2020

Y1 - 2020

M3 - Journal Article

SN - 0270-9139

VL - 72

JO - Hepatology

JF - Hepatology

ER -